The American Benefits Council is urging Congress to consider the cost to employers, workers and their families as it proposes ...

The pharmaceuticals lobby shored up its campaign against increasing use of the 340B Drug Discount Program with a new analysis ...

Vt., today introduced the 340B Patients Act, AHA-supported legislation that would codify 340B providers' ability to use contract pharmacies to distribute 340B discounted drugs. The bill would clarify ...

CMS' 2026 Outpatient Prospective Payment System proposed rule includes a provision that would increase the reduction in OPPS payment rates to offset the lump sum payments previously paid to 340B ...

Lawmakers in the House and Senate introduced legislation this week that could prohibit pharmaceutical companies from restricting access to 340B drug pricing discounts. The Pharmaceutical Access to ...

States lost $2.3 billion in Medicaid drug rebates in 2024 due to the expanded 340B program, with Pennsylvania, Illinois, and Massachusetts hit hardest.

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we ...

Believes In – Oppose it Join BlackDoctor.org (BDO) as we sound the alarm to oppose the 340B PATIENTS Act, which – if not ...

Ninety-three percent of hospitals responding to a recent survey conducted by 340B Health said they would struggle to maintain current levels of uncompensated care in the wake of drugmakers’ proposed ...

Second, the 340B program creates adverse incentives that increase overall healthcare costs and decrease patient choice. For instance, independent doctor’s practices do not qualify for 340B status.

The U.S. District Court for the Eastern District of Missouri July 11 granted a motion by the state to dismiss claims by ...

On July 15, 2025, the Centers for Medicare & Medicaid Services (CMS) released the CY 2026 Outpatient Prospective Payment System (OPPS) proposed ...